Thepar region of bacteriophage P7 is responsible for active partition ofthe P7 plasmid prophage into daughter cells. The cis-acting partition site was defined precisely as a 75-bp sequence that was necessary and sufficient to promote correct segregation of an unstable vector plasmid when the two P7 partition proteins, ParA and ParB, were supplied in trans. Roughly the same region was necessary to exert partition-mediated incompatibility. The minimal site contains an integration host factor (IEHF) protein binding site bracketed by regions containing heptamer repeat sequences that individually bind ParB. An additional sequence forms the left boundary of the site. Site-directed mutations in the latter sequence, as well as the IHF motif and the rightmost ParB box, blocked site function. Although the P7 site shares 55% sequence identity with its counterpart in bacteriophage P1, functional interactions between the partition sites and the Par proteins of the two plasmids were entirely species specific in vivo. The P1 sequence has similar IHF and ParB binding motifs, but the left boundary sequence differs radically and may define a point of species-specific contact with the Par proteins. No evidence was found for the existence of a functional P7 analog of the P1 parS core, a small subregion of the P1 site that, in isolation, acts as an enfeebled partition site with modified incompatibility properties.
Bacterial plasmids encode a variety of distinct mechanisms designed to ensure their stable inheritance at cell division (30) . In addition to site-specific plasmid resolution and cell-killing systems (30) , loci implicated in active partition have been identified on a number of low-copy-number plasmids (23, 30, 37) . Such systems are critical for plasmids whose copy number is too low to depend wholly on passive cytoplasmic diffusion to guarantee their faithful segregation.
Bacteriophage P1 lysogenizes its Escherichia coli host as a highly stable unit-copy plasmid (6) . This remarkable stability is primarily due to an active partition system composed of two essential trans-acting genes, parA and parB, and a downstream cis-acting site, parS, which appears to be functionally analogous to a eukaryotic centromere (3, 4, 18, 28) . The parB gene encodes a site-specific DNA binding protein (ParB) that has been postulated to recognize a set of heptamer repeats inparS (14) . The host protein, integration host factor (IHF), binds cooperatively with ParB at parS (14, 15, 19) , at which it induces DNA bending in vitro (20) . Although both the ParA and ParB proteins are essential for partition (18) , no direct binding of ParA to parS has been detected.
ParA is a member of a diverse group of ATPases that function in plasmid maintenance (16, 29) . TheparA andparB genes form an autoregulated operon. Although ParA is the only protein known to bind directly to the operon promoter region (16) , both ParA and ParB are required for complete par operon transcriptional autoregulation (18) .
Plasmids that share the P1 partition region express mutual incompatibility (3) . This characteristic is most conveniently explained by considering plasmids a pool from which individuals are selected randomly for pairwise partition (31) . Two plasmids that share the same partition site cannot be distinguished from each other during the partition process, and random assortment ultimately gives rise to populations that have one or the other plasmid but not both. The P1 par incompatibility effect has been termed IncB+ (2, 15) . As the crucial recognition locus for P1 partition is parS, the parS * Corresponding author.
site and the determinant for IncB+ should be the same locus. This proves to be the case (4) . The limits of the sequence that confers the IncB+ phenotype have been mapped to an 84-bp region (15; Fig. 1 ). This 84-bp site (parS) is necessary and sufficient to stabilize low-copy-number plasmid constructs when P1 partition proteins are supplied in trans. However, in specific contexts, a 22-bp sequence internal to the 84-bp region retains significant parS activity (27) . This parS core sequence appears to be an inefficient site, as plasmids that rely on it for partition are less stable than their wild-type counterparts and are incapable of competing in incompatibility tests with par plasmids containing wild-type sites (15, 28) . Although the parS core site is enfeebled and functions only in specific contexts (22) , it must contain key information for partition. The core sequence binds ParB and consists of a pair of inversely repeated heptamer boxes and some adjacent sequences (27; Fig. 1 ). Deletion and substitution mutations in this 22-bp sequence fully abolishparS-mediated partition activity (27) .
P7 is a bacteriophage closely related to P1, with which it shares an active partition system that likely originates from a common ancestral source (26) . However, while the P1 and P7 plasmid partition operons are homologous and collinear, mutations in PlparA andparB are not complemented by the equivalent P7 genes and vice versa (26) . Similarly, while the P1 and P7 cis-acting partition sites are unequivocal homologs and possess identically spaced IHF and ParB binding motifs (26; Fig. 1 (8) . CC1531, CC1532, CC1577, CC1579, and CC1596 are CC1572 transformants that harbor pGB2, pALA480, pBR322, pALA271, and pALA1023, respectively. Bacteriophage X stocks were maintained on strain YMC (supF) (17) . Phage Ximm21-P7:79Cm is a derivative of imm21-P7: 79 (25) . The cat gene was introduced into X-P7:79 by homologous recombination as described previously for the construction of XcI857-P1:5RCm (15) . X-P7:79Cm lysogenizes E. coli as a stable unit-copy miniplasmid directed by the P7 plasmid maintenance system. Similarly, XcI857-P1:5RCm replicates as a low-copy-number P1 miniplasmid driven by the P1 replication and partition regions (15) . Bacteriophage XcI857-P1:5RA1005 contains the P1 replication region but no partition sequences (5) . Plasmids. Plasmid pALA271 (2) consists of the P1 parA and parB genes cloned in pBR322 (9) . Plasmids pALA407 (28) and pALA1693 contain a 109-bp TaqI-StyI parS sequence of P1 cloned in pBR322 and the partition pickup assay vector, pALA1626, respectively. Plasmid pALA480 contains the P7 parA and parB genes subcloned in pGB2 (12) as an EcoRI-HindIII fragment from pALA1023 (26) . Plasmids pALA1602 (P7 bp 2382 to 2476), pALA1609 (P7 bp 2301 to 2476), pALA1611 (P7 bp 2335 to 2476), pALA1613 (P7 bp 2301 to 2451), and pALA1614 (P7 bp 2335 to 2450) (see Fig. 2 ) contain overlapping restriction fragments from the vicinity of P7 parS and cloned as blunt-end segments in EcoRV-cleaved pBR322. Plasmid pALA481 consists of a BglII-DraI fragment (P7 bp 1946 to 2450) spanning P7 parS and cloned into BamHI-EcoRVcleaved pBR322. Plasmid pALA1601 (see Fig. 2 ) was constructed by restricting pALA481 with XmnI and religating it, thereby generating a deletion derivative of pBR322 containing P7 bp 2382 to 2451. Similarly, pALA1616 (P7 bp 2301 to 2382) is a deletion derivative generated by digesting pALA1609 with XmnI and religating it.
Plasmid constructs for mapping of the right boundary of P7 parS were made as follows. Insertion of a doublestranded blunt-end synthetic 30-bp linker containing unique StuI, BglII, and SmaI sites in XmnI-digested pALA1616 generated pALA1617. The latter plasmid therefore contains P7 bp 2301 to 2391 immediately followed by restriction sites into which synthetic oligonucleotides composed of different lengths ofparS sequence to the right of position 2390 were conveniently cloned in a manner that facilitated the exact reconstruction of P7 sequences at the insertion point. Plasmids pALA1621 to pALA1625, pALA1630, pALA1638, pALA1639, pALA1645, and pALA1672 (see Table 3 , set A) were generated in this fashion by use of double-stranded oligonucleotides with ends complementary to StuI and BglII sites.
Plasmid constructs for determining the left boundary of parS were made as follows. A 66-bp sequence (P7 bp 2335 to 2400) containing a defined right partition site boundary was purified as a HinPI-SmaI fragment from pALA1638 and ligated simultaneously to (i) a double-stranded 37-bp synthetic oligonucleotide containing bp 2301 to 2334 (but with a C-to-G mutation at position 2332) and EcoRV and HinPI complementary ends and (ii) EcoRV-digested pBR322. This procedure produced plasmid pALA1648, which contains P7 bp 2301 to 2400 but with a C-to-G substitution at position 2332 that results in the formation of a unique BssHII site at this position. In addition, the P7 material in this construct is flanked by EcoRV and BglII sites at the left and right boundaries, respectively. Double-stranded synthetic oligonucleotides composed of different lengths of partition site sequence to the left of position 2333 were introduced into EcoRV-BssHII-digested pALA1648 to generate pALA1649 to pALA1653, pALA1673, and pALA1675 (see Table 3 , set B).
The pBR322-and pALA1626-based plasmids (pALA1753 to pALA1756 and pALA1757 to pALA1760, respectively) containing site-specific mutations in the minimalparS region were generated by inserting oligonucleotides with the appropriate mutations and EcoRV and BamHI compatible ends in EcoRV-BamHI-cleaved pBR322 and pALA1626 (see Fig. 4 ). Plasmids containing wild-type parS regions and similar flanking vector sequences for use as controls were the pALA1626-based plasmid pALA1659 (see Table 3 , set B) and the pBR322-based plasmid pALA1770. The latter plasmid was generated by digesting pALA1652 (see Table 3 , set B) with BamHI (34) and further treated with the GeneClean kit (Bio 101, Inc., La Jolla, Calif.) as suggested by Tiesman and Rizzino (36) . Plasmid-specific sequencing primers were annealed to NaOH-denatured double-stranded DNA under conditions described previously (36) . Sequencing was performed by the dideoxynucleotide chain termination method (35) (11) , except that dimethyl sulfoxide was omitted from the transformation and storage solution.
Partition tests. Partition tests were performed by a pickup assay with a high-copy-number P1 miniplasmid vector (1) . Plasmid pSP102 (32) is a P1 miniplasmid that contains no partition sequences, has a deletion of the copy number control locus, incA, and replicates at a moderate copy number. The introduction of a synthetic multiple cloning region in the BamHI site of pSP102 generated plasmid pALA1626, which contains adjacent unique AvaI, BamHl, BglII, BssHII, ClaI, EcoRV, SphI, XbaI, and XhoI restriction sites, allowing the more convenient manipulation of sequences. P7 partition sites to be tested for activity were subcloned into this multiple cloning region from the set of pBR322 derivatives described above and transformed into recombination-proficient strain YMC. Bacteriophage X-P1: 5RA&1005 was grown on these YMC transformants, and the phage lysate containing in vivo composite pALA1626:: X-P1:5RA1005 phage was used to lysogenize CC1572 derivatives, with selection for pALA1626-encoded chloramphenicol resistance at 32°C. Because X-P1:5RA1005 lacks sequences essential for chromosomal integration (5), the recombinant prophage replicates as a plasmid directed by the P1 replication machinery. In addition, because the recombinant phage possess the copy number control locus incA, replication proceeds at a low copy number (7) . The maintenance stability of the composite prophage plasmid following approximately 25 generations of unselected growth when partition proteins were supplied in trans on a compatible plasmid was used as an indicator of whether an active partition site was present on the cloned insert as follows. Eight chloramphenicol-resistant lysogens were streaked for single colonies on chloramphenicol-containing L agar at 32°C for 24 h. Eight of the resulting colonies from this initial selection were restreaked on nonselective L agar at 32°C for 24 h. This step was repeated, and eight individual colonies from each of the final eight streaks were tested for retention of the chloramphenicol resistance marker by being picked and stabbed to L agar containing chloramphenicol at 32°C.
Partition-mediated incompatibility tests. Incompatibility tests with X-P7:79Cm were performed at 32°C essentially as described previously for X-P1:5RCm (27) . In brief, strain N100 or RW1840 was lysogenized with X-P7:79Cm, with selection for chloramphenicol resistance. Lysogens were transformed to ampicillin resistance with the pBR322-based test plasmid and restreaked once on ampicillin-containing medium. Following growth under nonselective conditions for approximately 25 generations as described above, transformants were assayed for X-P7:79Cm retention.
Protein purification and DNA footprinting assays. Purification of IHF and P7 ParB proteins and conditions for DNase I protection assays (21) were described by Davis et al. (14, 16) . DNA fragments for footprinting analyses were end labelled and amplified from pBR322-based plasmids by the polymerase chain reaction with vector-derived primers flanking the cloned P7 sequences essentially by the method of Hooft van Huijsduijnen (24) . End-labelled fragments were purified by polyacrylamide gel electrophoresis.
RESULTS
Assay system for P1 and P7 partition sites. Successful partition site assays use conditional vector systems that can be maintained at either a high or a low copy number (1). The high-copy-number state is convenient for the manipulation of DNA and is necessary for long-term maintenance of partition-defective derivatives. However, plasmid maintenance stability due to par must be tested in the low-copynumber mode, in which the partition system has an easily measurable phenotype. Previously, the dual replicon vector pALA136 was used for mapping the P1 partition site (27, 28) . The high-copy-number ColEl-derived replication origin of pALA136 is suppressed in apolA host, in which replication proceeds at a low copy number solely via the P1 replication region. This system allows an estimate of plasmid maintenance stability due to cloned partition sites when Par proteins are provided in trans on a compatible plasmid (28) . While this protocol works with modest efficiency with Plpar sites, P7 par site activity has proven weak and inconsistent (22) . The sequence context and/or small size of this vector may impose on the inserted par sites restrictions that are partially tolerated by the P1 site but less well by its P7 analog (7). An alternative assay suitable for the comparative analysis of both par sites was therefore developed (1; see Materials and Methods). Potential partition sites are cloned into a moderate-copy-number mutant (incA) P1 miniplasmid. The sites are tested after recombinational pickup onto a phage X vector that supplies the missing P1 incA locus. The resulting composite replicates at a low copy number (7), and the efficacy of the cloned par sites can be estimated by measuring the maintenance stability of the hybrid when the appropriate Par proteins are supplied in trans on a compatible plasmid. A fragment encompassing the entire P1 parS region confers stability in response to the P1 Par proteins, and the level of stabilization achieved (>80% retention in 25 generations) is substantially higher than that in the previously used assay (approximately 40% retention; 28). The limits of the functional P1 parS site in the new assay are approximately equivalent to those of the previously defined P1 IncB+ region (Fig. 1) . However, shorter sequences, including the core 22-bp site, are nonfunctional (22) .
Identification and specificity of the P7 plasmid incompatibility and partition locus. The P1 parS region determines both partition site and incompatibility properties. It contains a number of distinctive protein binding motifs, including a set of heptamer repeat sequences recognized in vitro by ParB and an IHF binding site (14, 15; Fig. 1 ). Specific mutations in the IHF binding site or in the ParB heptamer repeat boxes affect partition ability and/or partition-mediated incompatibility (15, 20, 27 ( Fig. 1) . For investigation of whether this P7 region also functions as both an incompatibility locus and a partition locus, a 176-bp Fnu4HI-HincII fragment completely spanning this region (Fig. 1) was tested for these properties. When a pBR322 derivative containing the fragment (pALA1609) was introduced into cells containing P7 unitcopy miniplasmid X-P7:79Cm, the latter plasmid was displaced efficiently (Table 1) . Furthermore, in partition assays, the same fragment promoted stability of the X pickup vector (pALA1664). This activity was dependent on both the presence of the fragment in the stabilized plasmid and the P7 Par proteins that were supplied in trans (Table 2 ). These results indicate that the 176-bp Fnu4HI-HincII sequence of P7 contains sufficient cis-acting information for both the active partition process and partition-mediated incompatibility.
The incompatibility specificities of the P1 and P7 partition sites were examined by comparing the effects of pBR322 plasmids containing the P7 176-bp sequence or the P1 109-bp IncB+ sequence on the stability of P1 and P7 miniplasmids X-P1:5RCm and X-P7:79Cm (Table 1) . Partition-mediated incompatibility was expressed by these derivatives only towards miniplasmids carrying a site from the same species. Furthermore, partition tests with these fragments were also species specific: the partition site activity of the P7 fragment was supported when P7 proteins were provided in trans and not when P1 proteins were supplied, whereas the derivative containing the P1 109-bp IncB+ sequence was dependent on P1 proteins ( Table 2 ). The P1 and P7 partition sites are therefore plasmid specific, both in their abilities to support the active partition process and in the expression of partition-mediated incompatibility towards P1 and P7 miniplasmids.
Gross limits of the P7 parS site. By use of restriction sites a All values are the averages of at least three individual experiments ± 1 standard deviation. The indicated plasmid was incorporated into X pickup vector X-P1:5RA1005 and tested, as described in Materials and Methods, in the presence of pBR322 (which supplies no partition proteins) or pALA271 or pALA1023 (which supplies the P1 or P7 ParA and ParB proteins, respectively).
near the P7 partition region, a set of deletion variants of the 176-bp Fnu4HI-HincII fragment as constructed in pBR322 as outlined in Materials and Methods. The nucleotide sequences of the inserts were confirmed, and their associated incompatibility phenotypes were determined (Fig. 2) . Plasmids with deletions of the 82-bp Fnu4HI-XmnI fragment (pALA1601 and pALA1602) or of the 34-bp Fnu4HI-HinPI fragment (pALA1611 and pALA1614) no longer displaced P7 miniplasmid X-P7:79Cm. The leftmost boundary of the P7 IncB+ sequence therefore maps between the Fnu4HI and HinPI sites. Similarly, the rightmost boundary is located between the XmnI and DraI sites, because deletion of the 68-bp XmnI-DraI sequence (pALA1616) but not of the 26-bp DraI-HincII sequence (pALA1613) abolished incompatibility. Furthermore, only plasmids containing IncB+ regions were segregated stably in partition tests when P7 ParA and ParB were supplied in trans (Fig. 2) . Partition site assays showed all IncB-fragments to be inactive (Fig. 2) , although the possibility that these negative results were an assaydependent phenomenon cannot be eliminated (see Discussion).
Precise mapping of the P7 parS boundaries. As outlined in Materials and Methods, the rightmost limit of P7 parS was determined by constructing a set of pBR322-based plasmids containing P7 bp 2301 to 2391 plus additional various portions of the interval from bp 2392 to bp 2421 (Fig. 3A) and assaying for partition-mediated plasmid incompatibility ( Table 3 ). In addition, these P7 sequences were subcloned in the partition assay pickup vector, pALA1626, and tested for partition ability (Table 3) . The structures of all plasmids tested were confirmed by sequence analysis. Plasmids containing bp 2301 to 2400 expressed complete incompatibility towards P7 miniplasmid X-P7:79Cm (<2% retention) and were also partition proficient (>70% retention) in the pickup assay system when P7 partition proteins were supplied on the compatible plasmid, pALA480. However, deletion of bp 2400 resulted in both a loss of incompatibility (pALA1624) and a marginal reduction in partition proficiency (pALA1632). Deletion of an additional nucleotide further decreased partition ability (pALA1684), while a plasmid containing bp 2301 to 2391 (pALA1633) was fully Par- (Fig.  3A and Table 3 ). Thus, the rightmost limits of the incompatibility and partition determinants roughly correspond and lie in the vicinity of nucleotide 2400.
Plasmid pALA1648 is a pBR322-based plasmid containing P7 bp 2301 to 2400 but with a C-to-G substitution mutation at bp 2332, which results in the formation of a unique BssHII site at this position (Fig. 3B) . In addition, the leftmost P7-pBR322 junction of this plasmid is flanked by a unique EcoRV site. The leftmost boundary of the parS region was defined by substituting bp 2301 to 2333 with synthetic double-stranded oligonucleotides composed of different lengths of P7 material and with EcoRV-and BssHII-compatible ends (Fig. 3B and Table 3 ). Deletion of bp 2301 to 2325 had no dramatic effect on either incompatibility or partition ability. However, deletion of bp 2326 (pALA1651) resulted in a sharp decrease in the degree of incompatibility exerted by the P7 sequence, while elimination of an additional 2 nucleotides (pALA1657) significantly lowered the retention frequency in partition assays. Partition ability was eliminated by the loss of nucleotide 2329 (pALA1656). Thus, the leftmost boundaries of the incompatibility determinant and partition site are roughly coincident around nucleotide 2325. The minimal parS site is therefore about 75 bp in size (bp 2326 to 2400). However, because clones possessing an extra 3 bp at this leftmost limit yielded somewhat more reproduc- ible results in both partition site and incompatibility assays, this 78-bp sequence (bp 2323 to 2400) was used for subsequent mutational analyses. Does the P7 parS region exhibit dual incompatibility specificities? Although the intact P1 parS region is required for wild-type (IncB+) incompatibility, the 22-bpparS core (Fig.  1 ) is also capable of exerting an incompatibility effect under specific circumstances (15, 27, 28) . Plasmids containing this site cannot displace a P1 miniplasmid from a wild-type strain but can displace one from strains lacking an IHF protein (19) . This limited incompatibility property is termed IncBd (15) . Several different fragments lacking portions of theparS region but retaining the parS core share this property (27) .
For assessment of whether a comparable situation exists for the P7 parS region, the group of pBR322 clones described previously was tested for the ability to eliminate a P7 miniplasmid in incompatibility tests with strain RW1840 (IHF-). Inspection of Fig. 2 shows that, in the case of P7, the full-length parS fragment was essential for exerting incompatibility in the IHF-strain. Shorter fragments that retain the P7 region that is homologous to the P1 parS core region showed, at best, only a marginal ability to expel X-P7:79Cm in the IHF-defective background, and the smallest such fragment had no effect at all. Thus, in contrast to the P1 case, there is no evidence for the existence of a P7 parS core sequence with IncBd activity.
Site-directed mutational analysis of the P7 minimal parS region. Extensive fine-structure analysis of the P1 parS region has defined motifs critical to parS-mediated incompatibility specificity and partition ability (15, 27) . The roles of selected related sequences in the P7 minimal parS region were probed by cloning synthetic oligonucleotides with multiple mutations in two of the three ParB heptamer repeat boxes, in the IHF binding site, and in the region adjacent to the leftmost boundary of the minimal parS site (Fig. 4) . Mutations in the P7 ParB and IHF binding motifs were chosen to match alterations known to have a deleterious effect on expression of the P1 IncB+ phenotype (15) . Suitable constructs containing these oligonucleotides were tested for incompatibility and partition ability (Table 4) . Plasmids harboring alterations in the rightmost ParB box (pALA1756), the IHF binding site (pALA1755), or the region adjacent to the leftmost boundary (pALA1753) failed to displace a P7 miniplasmid in incompatibility tests (Table 4) 
(B)
Determination of the leftmostparS boundary. Symbols correspond to those described in panel A, except that vertical arrows indicate the final leftmost nucleotide ofparS-containing subclones. The C-to-G base change at position 2332 generated a novel BssHII site at this position (see Materials and Methods) while simultaneously abolishing incompatibility and partition abilities (data not shown).
rightmost boundary of the wild-type site were protected from DNase I digestion by ParB (Fig. 5, lower region of gel) . This region includes two inversely oriented copies of the proposed ParB heptamer recognition element, with the sequences ATIT'TCAG and CTGAAAT (Fig. 4) . ParB also weakly protected a region that includes the leftmost ParB heptamer ATITCAT (Fig. 4) and extends somewhat beyond the leftmost boundary of the partition site (Fig. 5, upper region of gel). IHF protected a region that includes the 13-bp putative IHF binding motif and additional bases, mostly to the right of the motif. ParB and IHF together produced a pattern similar to the sum of the separate effects, but the protection was more complete. Protection from the leftmost boundary through the leftmost heptamer was now clearly seen.
Although the rightmost ParB heptamer motif was rather poorly cut by DNase I, inspection of Fig. 5 (and of overexposed versions not shown) shows that ParB protected it and that this protection was complete in the presence of IHF. The introduction of multiple mutations into this box (pALA1756) altered and improved the basic DNase I cutting pattern of the region, making the protection experiments easier to interpret. ParB binding to this mutated box was eliminated, but binding to the adjacent box persisted. Thus, the heptamer motif is an individual ParB binding site, as has been speculated for the P1 system (14) . IHF binding to the central region was unaffected by the mutation in pALA1756, but careful inspection of the leftmost boundary of the site (closed boxes; Fig. 5 ) suggests that ParB binding here was less complete than in the wild-type case.
The set of mutations introduced into the putative IHF box (pALA1755; Fig. 4 ) completely eliminated the recognition of this site by the IHF protein (Fig. 5) , a result confirming the identity and location of the IHF site (Fig. 4) . The pattern of ParB binding to this mutated sequence was unaltered in comparison with the pattern obtained when ParB alone bound to the wild-type site (Fig. 5) . Although both sets of mutations introduced into the leftmost end of the P7 minimal partition site (Fig. 4) had effects on partition and incompatibility in vivo (Table 4) , neither set of substitutions had an obvious impact on ParB or IHF binding in vitro (data not shown). However, as the in vitro protein-DNA interactions in this region of the wild-type sequence are weak (Fig. 5) , alterations in the binding affinities due to the mutated bases may be difficult to detect.
DISCUSSION
The partition systems of the P7 and P1 prophage plasmids are substantially homologous and presumably originate from a common ancestral source (26) . However, they have diverged sufficiently so that the cis-acting partition sites support plasmid segregation only when provided with their cognate proteins ( Table 2 ). The partition systems also demonstrate species specificities in partition-mediated incompatibility (26; Table 1 ) and Par operon autoregulation (33) . These species specificities presumably reflect steps in a pathway for partition at which macromolecular components recognize each other and at which elements from different sources fail to function correctly together. By mapping the specificity determinants to specific proteins, protein domains, and DNA sites, it should be possible to define an A. important subset of interactions involved in partition. This process requires the development of a convenient assay capable of efficient detection of both P7 and P1 partition site activities. The pickup assay protocol described here fulfills this requirement. With this technique, a detailed characterization of the P7 cis-acting partition site,parS, whose extent and exact location were previously unknown, was performed. The P7 minimal partition site was defined precisely and shown to be 75 bp in size, with a partial requirement for an additional 3 nucleotides at the leftmost boundary. The minimal partition site includes essential ParB and IHF binding motifs and novel sequences at the leftmost boundary. Three of the P1 heptamer boxes speculated to direct ParB binding (14) have homologs in the P7 minimal site. The heptamer motifs have been shown here to be individual ParB binding sites, as destruction of the rightmost heptamer motif by multiple mutations (Fig. 4) blocked binding to the disrupted box, whereas binding to its adjacent wild-type partner was maintained (Fig. 5) . The integrity of the boxes, both here and toward the leftmost end of the site, is essential for function of the minimal partition site, as the introduction of multiple mutations into these boxes eliminated or reduced both partition and incompatibility activities in vivo (Table 4) .
The central IHF binding motif in P7 is considerably divergent from its P1 counterpart. However, the P7 sequence binds IHF, which is essential for the activity of the minimal partition site in vivo (Table 4) . IHF promotes more efficient ParB binding, perhaps by cooperative interactions of the two proteins. It seems probable from the known properties of IHF (38) that IHF binding induces a severe bend in the DNA (20) that promotes an interaction between the two ends of the site. This interaction could account for the apparent weakening in protection of the leftmost end of the site when the rightmost ParB box is mutated (Fig. 5) Like its homolog in the P1 plasmid (3), the P7 partition site also functions as a partition-mediated plasmid incompatibility determinant. This function is thought to reflect a critical pairing of plasmids via their partition sites (31) . An incoming replicon carrying the relevant partition site competes with a resident plasmid for partition by forming inappropriate pairs prior to segregation (15, 31) . As the entire P7 75-bp minimal partition site is required to exert incompatibility, it appears that pairing with the wild-type region requires the integrity of the complete site. However, a number of partition site deletion constructs that retained significant partition ability but exhibited little or no incompatibility with a P7 miniplasmid were identified (Table 3 ). This result may reflect site damage that weakens the pairing reaction, such that daughter plasmids are still able to pair and segregate in the pickup assay, but competition for pairing with wild-type resident plasmids in the incompatibility test is poor.
The P7 and P1 partition sites share 55% identity over the P7 75-bp minimal partition site. The relative spacings of the ParB and IHF protein binding motifs are conserved perfectly (Fig. 1) , and there is no clearly defined consensus difference between the P7 and P1 heptamer boxes. The overall configurations of these sites, when present in an active plasmid partition complex, are probably similar. The structure may consist of partition site sequences wrapped about a central ParB-IHF protein core with its ends in proximity to each other (15) . However, the relative importance of different elements in maintaining an active structure seems to have diverged considerably between the two species. A P1 heptamer box at the right end of the P1 locus is essential for wild-type P1 incompatibility (15) , but its counterpart in P7 is redundant (Fig. 3A) . In contrast, the leftmost P7 heptamer box is required for full activity of the minimal partition site (Table 4) , whereas the properties of similar, although not strictly comparable, P1 constructs suggest that the equivalent box is dispensable in P1 (15) . Another major difference concerns the function of the 22-bp region referred to, in P1, as the parS core (Fig. 1) . The isolated P1 sequence shows modest partition site activity (27) and exerts modified (IncBd) incompatibility (15, 28 (Fig.  4) . Asterisks mark the boxes containing multiple mutations (Fig. 4) . WT, wild-type sequence; pALA1755, multiple mutations introduced into the IHF box (Fig. 4) ; pALA1756, multiple mutations introduced into the rightmost ParB box (Fig. 4) . Lanes: 1, no protein added; 2, relevant P7 subregion has any partition site activity in isolation (Fig. 2) , and no IncBd-like activity was seen for this P7 subregion when either P7 (Fig. 2) or P1 (22) miniplasmids were used as targets. One or more of just 4 base differences between the P1 and P7 22-bp core regions are presumably responsible for this important difference. The P1 core region may contain the critical information for partition, and the adjacent regions may form a structure in which this information is optimally presented (15) . It seems probable that a similar situation occurs in P7 but that, in this case, the critical core sequences are unable to function at all in the absence of the supporting sequences. The construction and in vivo and in vitro characterization of chimeric partition sites should assist further in defining the crucial determinants of P7 and P1 partition site specificities.
